SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-181673
Filing Date
2024-07-19
Accepted
2024-07-19 16:31:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d873142ds3.htm S-3 340131
2 EX-4.4 d873142dex44.htm EX-4.4 299909
3 EX-5.1 d873142dex51.htm EX-5.1 33448
4 EX-23.1 d873142dex231.htm EX-23.1 1784
5 EX-FILING FEES d873142dexfilingfees.htm EX-FILING FEES 79030
6 GRAPHIC g873142dsp104.jpg GRAPHIC 4353
7 GRAPHIC g873142g03k03.jpg GRAPHIC 42239
  Complete submission text file 0001193125-24-181673.txt   819853
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280918 | Film No.: 241128138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)